TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Qiagen Tumbles on Sales Warning, CEO Departure
Play
INVESTING

Qiagen Rises on Launch of Covid Antigen Test

  • By Vidhi Choudhary
  • Nov 12, 2020 1:11 PM EST
PRESS RELEASES

QIAGEN Receives FDA Emergency Use Authorization For NeuMoDx Multiplex Test Expanding COVID-19 Portfolio

  • By Business Wire
  • Mar 29, 2021 2:00 AM EDT
PRESS RELEASES

QIAGEN Announces 20-F Annual Report Filing For 2020 Results

  • By Business Wire
  • Mar 5, 2021 6:05 AM EST
PRESS RELEASES

QIAGEN Launches QIAsphere Cloud-Based Connectivity Solution To Enhance QIAstat-Dx Capabilities In Digital Diagnostics

  • By Business Wire
  • Mar 3, 2021 4:10 PM EST
PRESS RELEASES

QIAGEN Launches QIAcube Connect MDx Platform For Automated Sample Processing In Diagnostic Labs

  • By Business Wire
  • Mar 2, 2021 4:11 PM EST
PRESS RELEASES

QIAGEN And INOVIO Expand Collaboration To Develop Next Generation Sequencing (NGS) Companion Diagnostic For INOVIO's VGX-3100 For Advanced Cervical Dysplasia

  • By Business Wire
  • Feb 24, 2021 1:45 AM EST
PRESS RELEASES

QIAGEN Expands Supervisory Board With Appointment Of A New Member

  • By Business Wire
  • Feb 22, 2021 4:08 PM EST
PRESS RELEASES

QIAGEN Beats Outlook For Fourth Quarter And Full-Year 2020, Reaffirms Expectations For Further Growth In 2021

  • By Business Wire
  • Feb 9, 2021 4:05 PM EST
PRESS RELEASES

QIAGEN Adds DPCR Platform QIAcuity To Growing Portfolio Of COVID-19 Testing Solutions For Wastewater And Mutation Testing

  • By Business Wire
  • Jan 28, 2021 4:05 PM EST
PRESS RELEASES

QIAGEN N.V. To Report Fourth Quarter And Full-Year 2020 Results

  • By Business Wire
  • Jan 26, 2021 7:10 AM EST
PRESS RELEASES

QIAGEN Plans To Resubmit EUA Submission In The U.S. For QIAreach SARS-CoV-2 Antigen Test In The First Quarter Of 2021

  • By Business Wire
  • Jan 20, 2021 4:08 PM EST
PRESS RELEASES

QIAGEN Confirms Effectiveness Of Its SARS-CoV-2 PCR Tests In The Face Of Mutations Of The Coronavirus

  • By Business Wire
  • Jan 20, 2021 4:05 PM EST
PRESS RELEASES

QIAGEN Announces Appointment Of New Supervisory Board Member

  • By Business Wire
  • Jan 8, 2021 7:00 AM EST
PRESS RELEASES

QIAGEN Underlines And Innovates Its Commitment To Sustainability With A EUR 400mn Sustainability-linked Credit Facility

  • By Business Wire
  • Dec 17, 2020 4:05 PM EST
PRESS RELEASES

QIAGEN Increases Outlook For 2020 And 2021

  • By Business Wire
  • Dec 8, 2020 1:45 AM EST
PRESS RELEASES

QIAGEN To Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread And Control Of COVID-19 Through T-cell Response

  • By Business Wire
  • Dec 7, 2020 2:00 AM EST
PRESS RELEASES

QIAGEN Collaborates With BioNTech On Companion Diagnostics Development For HPV-associated Squamous Cell Carcinoma Of The Head And Neck

  • By Business Wire
  • Nov 18, 2020 4:05 PM EST
PRESS RELEASES

Leading Diagnostics Companies Join Forces To Establish The Access To Comprehensive Genomic Profiling Coalition (ACGP)

  • By PR Newswire
  • Nov 17, 2020 8:00 AM EST
PRESS RELEASES

QIAGEN Launches NeuMoDx Multiplex Test To Complete Range Of SARS-CoV-2 Testing Solutions In Europe And Other Markets

  • By Business Wire
  • Nov 16, 2020 4:05 PM EST
Qiagen Tumbles on Sales Warning, CEO Departure
INVESTING

Qiagen Rises on Launch of Covid Antigen Test

  • By Vidhi Choudhary
  • Nov 12, 2020 1:11 PM EST
PRESS RELEASES

QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour

  • By Business Wire
  • Nov 11, 2020 4:05 PM EST
PRESS RELEASES

QIAGEN N.V. To Hold Investor Call On Wednesday, October 28, After Releasing Results For Q3 2020 And First Nine Months Of 2020

  • By Business Wire
  • Oct 27, 2020 1:04 PM EDT
PRESS RELEASES

QIAGEN Reports Strong Results For Third Quarter And First Nine Months Of 2020 And Increases Outlook For Full-Year 2020

  • By Business Wire
  • Oct 27, 2020 12:59 PM EDT
PRESS RELEASES

QIAGEN Reports Strong Preliminary Results For Third Quarter Of 2020

  • By Business Wire
  • Oct 13, 2020 8:45 AM EDT
PRESS RELEASES

QIAGEN Fully Acquires NeuMoDx Molecular, Inc., Rounding Out Portfolio Of PCR-based Diagnostic Automation Systems

  • By Business Wire
  • Sep 17, 2020 4:05 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.